| Health / Medical Topics |
Folate Receptor-Targeted Vinca Alkaloid EC0489
A folate receptor-targeting cytotoxic drug conjugate consisting of a folate vitamin analogue linked to a vinca alkaloid microtubule destabilizing agent with potential antineoplastic activity. Mediated through its folate moiety, folate receptor-targeted vinca alkaloid EC0489 delivers the cytotoxic vinca alkaloid moiety directly to cells expressing folic acid receptors, frequently upregulated in many types of tumor cells. After ligand-receptor internalization, the vinca alkaloid moiety binds to tubulin and disrupts microtubule assembly-disassembly dynamics, resulting in cell cycle arrest and apoptosis. The relative tumor cell specificity of this agent reduces the toxicity profile of its vinca alkaloid moiety. (NCI Thesaurus)
YOU MAY ALSO LIKE
An injectable targeted small molecule drug conjugate (SMDC) consisting of folate (vitamin B9) covalently linked to the potent mitotic poison and cytotoxic…
A folate receptor-targeting radiopharmaceutical consisting of a folate-containing tetrapeptide chelator to which technetium Tc 99m is linked. The folate component of folate…
A folate receptor-targeting antimitotic agent with potential antineoplastic activity. Folate receptor-targeted epothilone BMS753493 contains an epothilone moiety linked to a single folate…
Folate receptor beta (255 aa, ~29 kDa) is encoded by the human FOLR2 gene. This protein is involved in folic acid…
Encoded as 2 alternative isoforms by human FOLR1 Gene (FOLR Family), high affinity Folate Receptor 1 is a protein with eight disulfide…
Total folate activity which adjusts for the lower bioavailability of folate in food compared to folic acid using an accepted conversion…
